Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six Months Following Single Dose of WVE-007
Hillman Recognized by REDI Cincinnati with James A. Wuenker Growth Award for Forest Fair Mall Redevelopment Project
Luana Savings Bank Selects nCino to Unify and Transform Its Commercial and Agricultural Lending Operations
REX American Resources Reports Record High Full Fiscal Year 2025 Net Income Per Share Attributable to REX Common Shareholders of $2.50
Bridger Aerospace Names Justin Mogford as General Counsel, Further Strengthening Management Team
RVYL Shareholder Meeting Continued to April 1, with 99% of Votes Cast in Favor of Roundtable Merger
Identifying Details of New Security-ALUMA C1
Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735
Initiation of Phase 1/2a Study of GLIX1 for the Treatment of Glioblastoma (GBM)
The Lovesac Company Expands Share Repurchase Authorization by $40 Million